than half the rate in high-income countries (HIC). 2 This inequality galvanized the launch of the World Health Organization (WHO) Global Initiative for Childhood Cancer in September 2018 to improve survival rates to 60% by 2030. 3 WHO has designated 2020 as the Year of the Nurse and Midwife and highlights that nurses, together with midwives, constitute the largest group of health workers 4 ; therefore, strengthening nursing is critical to meeting this target.
Although WHO initiatives for nursing have generally prioritized primary care, 5 This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. health professionals, including nurses. Nurses in LMIC are frequently exposed to occupational hazards due to work environments that lack the required resources for safe care, such as personal protective equipment (PPE) for handling chemotherapy. 6, 7 The absence of specialized education, coupled with frequent rotation of trained staff, leaves nurses ill-equipped to safely deliver care for children/adolescents with cancer. 8 The Nurse Specialists of the Global Initiative for Childhood Cancer join public calls for all nurses (particularly those in resourcelimited settings), to be provided with protection when managing hazardous drugs as well as oncology specialization training to ensure optimal nursing care. [9] [10] [11] It is an ethical imperative that nurses are strengthened and equipped with knowledge and skills required to care for this vulnerable population and provided a safe environment for doing so.
Baseline standards for the provision of safe and effective nursing care in LMIC have been published by the Paediatric Oncology 12 The standards provide a framework for promoting a positive practice environment for care delivery (Table 1) and have received widespread endorsement (https://siop-online.org/baseline-nursing-standards/).
SAFE WORKING ENVIRONMENT
Chemotherapy is a standard treatment required to cure most childhood cancers. Nurses, pharmacists, and physicians who prepare chemotherapy, 13, 14 as well as hospital support personnel (e.g., cleaners and waste management staff) and families who are exposed to chemotherapy and hazardous waste, face immediate and long-term health risks, including cancer, miscarriages, and infertility. 15, 16 Adverse effects from hazardous drug exposure are entirely preventable with proper use of PPE for chemotherapy administration and biosafety cabinets for preparation, especially in settings without closed system transfer devices for chemotherapy administration as mandated in many HIC. 17, 18 Cost and supply chain challenges can be major barriers to reliable availability of essential devices and technology in LMIC. 19 Nonetheless, the cost of securing PPE for safe handling of chemotherapy and hazardous drugs and materials is minimal in comparison with other costs of scaling up cancer treatment. 20 It is not ethically defendable to invest in contemporary pediatric cancer treatment while failing to protect nurses and other health professionals from avoidable health risks in their work environments as recommended in numerous international guidelines. 11, 18 Given that PPE has been secured for infectious disease management (e.g., Ebola 21 ) and other public health threats, 22, 23 obtaining these resources to deliver chemotherapy safely is surely achievable.
There has been a persistent failure in LMIC to ensure access to PPE for safe preparation, administration, and disposal of chemotherapy for nurses, 8 pharmacists, and physicians. 14, 24 This includes chemotherapy-tested gloves, masks, protective eyewear and disposable impermeable gowns, 11 and at minimum, a level 2B biosafety cabinet with appropriate ventilation. 25 There is also a lack of appropriate training for health professionals in safe handling practices, 26, 27 although there are increasing efforts to address this. 28,29
SPECIALIZED PEDIATRIC ONCOLOGY NURSES
Investing in health workforce specialized education and training is supported by WHO Education Guidelines. 30 Given the complexity of pediatric cancer diagnoses, treatment, and care, nurses require specialized education and clinical training to deliver safe, quality care and reduce risk for patient harm. 10, 31 Specialized nursing education in all settings where children/adolescents with cancer are cared for, including operating rooms and intensive care units, improves quality and outcomes while strengthening broader health services. 32 Many train-the-trainer programs in pediatric oncology nursing have been conducted since the 1990s. However, few of these programs have established sustained specialized nursing education in either an incountry school of nursing or a hospital clinical setting, although successful programs have been established in Pakistan, Egypt, 10 Jordan, 33 Lebanon, 34 and Latin America. 35 Ultimately, successful specialized nursing education programs (from diagnosis through survivorship or palliative care) are those with local ownership and integration in officially recognized nursing education systems.
In too many countries, nurses are rotated between departments or for mandatory public health service, 32, 36 hindering achievement of increasing competence and expertise. 12 Pediatric oncology units require a dedicated nursing team with knowledge and experience in administering chemotherapy, monitoring side effects, managing oncology emergencies, and providing patient/family education. Developing this unique skill set is an inefficient investment unless arbitrary rotation of nurses is stopped, because knowledge and expertise is lost when nurses leave the unit. Nurse rotation also threatens retention and is a serious issue in LMIC 37 where nursing shortages are acute, 38, 39 specifically in pediatric oncology units.
ETHICAL ARGUMENTATION FOR MORAL ACTION
Historically, clinician exposure to health risks has been inherent to communicable disease treatment and guiding ethical principles have TA B L E 2 Ethical values as arguments for moral actions in supporting health professionals in childhood cancer care, adapted from Kass et al. 40 
Ethical values Moral actions
Respect It is imperative to acknowledge health professionals for their willingness to undertake emotionally distressing, highly advanced care, and potentially risky tasks. The role of the specialist nurse in the multidisciplinary childhood cancer care team needs to be acknowledged and respected.
Protect from harm
It is a duty to do no harm and to protect health professionals, as well as patients/families, from avoidable and preventable harm by providing nurses and pharmacists with adequate training and proper protective equipment. There has been a strong focus on standards of accountability for health care in LMIC, 9, 41 but historically, a lack of prioritization, or even neglect, of protective measures for nurses and others has been evident.
We must promote standards, identify incentives, and provide a solid rationale to institutions and governments to prioritize access to PPE for all those handling hazardous drugs, and, in parallel, advance specialized nursing roles and education to develop proficiency in pediatric oncology nursing care and optimize patient outcomes. 42 
IMPLICATIONS
The Nurse Specialists of WHO Global Initiative for Childhood Cancer urge WHO Member States and facilities delivering cancer treatment to prioritize safe nursing work environments and specialized education to improve overall population health. Health policy makers and hospital administrators can improve nurse recruitment and retention by creating a positive practice environment ensuring nurse occupational health and safety. 43 Promoting such environments through safe chemotherapy handling, specialized education, and nonrotation of nurses in WHO Member States is essential to improve the safety and outcomes of children/adolescents with cancer globally.
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